Try our beta test site
4 studies found for:    19684573 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.
Condition: Liver Disease
Intervention: Genetic: genotyping and/or sequencing
2 Completed Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C Treatment
Conditions: Hepatitis C;   Hepatitis C Relapse
Interventions: Drug: Pegylated Interferon α2;   Drug: Ribavirin
3 Unknown  A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV
Condition: Chronic Hepatitis C
Interventions: Drug: Victrelis® (boceprevir) 800mg by mouth, TID (200 mg tablets);   Drug: Peg-Intron® (peginterferon-α-2b), 1.5ug/kg sc injection;   Drug: Rebetol® (ribavirin), 1000/1200mg by mouth daily
4 Completed The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation
Condition: Hepatitis C Recurrence After Liver Transplant
Interventions: Drug: EVL arm;   Drug: MMF arm

Study has passed its completion date and status has not been verified in more than two years.